The Scientist - Home

A virtual reality study showed that the brain can detect potential infectious threats and prime the immune system, offering fresh insights into behavioral immunity.

AI-based simulation models are poised to help cell biologists cut costs, ask smarter questions, and do more with less.

A new AI tool that models how variations in peptides change T cell receptor binding could help design immunotherapies with fewer off-target effects.

A machine learning platform cut down discovery time of a T cell-based immunotherapeutic agent from years to weeks.

Australian researchers are using peptides isolated from spider venom to develop treatments for a range of neurological and cardiovascular disorders.

Mouse olfactory organoids revealed stem cells that preserve smell, offering clues to treat age- and disease-related smell loss.

Mosquitoes engineered to swap out an amino acid in a key protein were resistant to malaria infection, preventing them from transmitting the disease.

Using precision gene editing technology, researchers corrected mutations in the brains of mice with a devastating neurodevelopmental disorder.

Uri Manor’s own hearing loss may not have originally inspired his research path, but his work on the topic now may lead to new treatments and insights on aging.

Exposing people with similar types of breast cancer to radiation alone led to changes in tumor and immune cells, paving the way for novel treatment approaches.

The Nobel Prize-winning click chemistry technology allowed researchers to target tumors directly with a chemotherapy drug, preventing toxicity and side effects.

Contrary to long-standing assumptions, human egg cells stay pristine for decades not by ramping up waste disposal, but by dialing it down.